Satisfaction with injection experience of patients with neuroendocrine tumors enrolled on lanreotide autogel patient support programs: results from the international HomeLAN survey
Sign Up to like & getrecommendations! Published in 2023 at "Journal of Neuroendocrinology"
DOI: 10.1111/jne.13281
Abstract: Lanreotide autogel/depot (LAN) is a somatostatin analog used in first-line treatment for neuroendocrine tumors (NETs). The aim of HomeLAN was to evaluate the satisfaction with injection experience among patients with NETs receiving at-home LAN injection… read more here.
Keywords: injection; lan; survey; satisfaction ... See more keywords